Amundi Abiomed Inc Transaction History

Amundi

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $18.6 Million - $23.1 Million	76,742 Added 68.28%	189,134 $50 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $10.2 Million - $15.4 Million	45,469 Added 67.94%	112,392 $29.1 Million
Q1 2022 May 16, 2022	SELL	$277.25 - $366.29 $4.1 Million - $5.41 Million	-14,783 Reduced 18.09%	66,923 $21.3 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $1.95 Million - $2.41 Million	-6,499 Reduced 7.37%	81,706 $25.1 Million
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $1.05 Million - $1.27 Million	-3,375 Reduced 3.69%	88,205 $28.7 Million
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $24.1 Million - $32.2 Million	91,580 New	91,580 $28.6 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.